retatrutide clinical status A New Obesity Drug Delivered Surgery-Level Weight Loss in Trials Retatrutide - Wikipedia

You may also like FAQs Everything you need to know about Tirzepatide how it works, what to expect, and how to get started with a licensed provider

Where GLP-1 Patches Fit Into the Future of Treatment Discover how GLP-1 patches may reshape metabolic health care

Medications including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound were heavily marketed by pharmaceutical companies such as Novo Nordisk and Eli Lilly for blood sugar management, appetite reduction, and obesity treatment

It remains an investigational medicinal product (IMP), meaning it is only legally available to patients who are enrolled in authorised clinical trials conducted under strict ethical and regulatory oversight

The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. Also Read: Generic Semaglutide launches in India after patent expiry Side effects range from mild to severe Common side effects include nausea, vomiting, diarrhea, constipation, and loss of appetite